Par Pharmaceutical, US-based specialty pharmaceutical company, has announced the resignation of Lawrence Kenyon, executive vice president and chief financial officer (CFO), effective 30 June 2010, to pursue other opportunities. Michael Tropiano, Par’s treasurer, will replace Kenyon.
Tropiano joined Par in August 2005 as vice president and treasurer. During his tenure, he has led several initiatives including building a financial, planning and analysis team, developing the company’s three-year strategic plan, as well the early redemption of the company’s convertible debentures. Prior to joining Par, Tropiano served as vice president and corporate treasurer of MedPointe Pharmaceuticals from 2001-2005 and assistant treasurer at Carter-Wallace from 1984-2001. He began his career as a treasury analyst at Orange and Rockland Utilities. Tropiano received his MBA in Finance from Fordham University and a BA in Economics from Siena College. He is also a chartered financial consultant (CFC).
A report by broking group Marsh examines the repercussions from the administration of the South Korean company, which filed for bankruptcy protection at the end of August.
Global research by C2FO suggests that smaller businesses are less concerned with the repercussions of Brexit and the upcoming US presidential election.
A squeeze on skilled talent means it now takes an average of seven weeks to fill open permanent roles in finance in the UK according to new research from financial services recruitment firm Robert Half.
Early-stage merger and acquisition deals in Asia-Pacific show nearly 10% year-on-year growth in recent months.